Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 8 studies | 29% ± 9% | |
| ciliated cell | 3 studies | 19% ± 5% | |
| smooth muscle cell | 3 studies | 21% ± 6% | |
| goblet cell | 3 studies | 31% ± 10% |
Insufficient scRNA-seq data for expression of RNASE4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 10797.24 | 226 / 226 | 93% | 6.57 | 379 / 406 |
| intestine | 100% | 3729.60 | 964 / 966 | 58% | 1.48 | 304 / 527 |
| stomach | 100% | 4713.77 | 359 / 359 | 57% | 1.35 | 163 / 286 |
| kidney | 90% | 1829.60 | 80 / 89 | 66% | 2.08 | 595 / 901 |
| pancreas | 97% | 1695.75 | 319 / 328 | 57% | 1.31 | 102 / 178 |
| prostate | 100% | 4513.81 | 244 / 245 | 51% | 0.90 | 257 / 502 |
| breast | 100% | 7134.72 | 459 / 459 | 43% | 0.89 | 479 / 1118 |
| esophagus | 92% | 3088.33 | 1325 / 1445 | 40% | 1.05 | 73 / 183 |
| lung | 98% | 2933.44 | 568 / 578 | 24% | 0.59 | 275 / 1155 |
| bladder | 100% | 4675.62 | 21 / 21 | 17% | 0.29 | 84 / 504 |
| uterus | 100% | 5196.07 | 170 / 170 | 12% | 0.28 | 54 / 459 |
| ovary | 100% | 7311.26 | 180 / 180 | 5% | 0.08 | 21 / 430 |
| adipose | 100% | 6936.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5583.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.03 | 1 / 1 |
| skin | 95% | 2771.76 | 1714 / 1809 | 4% | 0.06 | 20 / 472 |
| thymus | 96% | 1941.64 | 630 / 653 | 2% | 0.03 | 15 / 605 |
| heart | 72% | 1369.06 | 617 / 861 | 0% | 0 | 0 / 0 |
| spleen | 51% | 583.54 | 123 / 241 | 0% | 0 | 0 / 0 |
| muscle | 27% | 318.69 | 217 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 18% | 181.93 | 47 / 258 | 1% | 0.02 | 3 / 230 |
| peripheral blood | 9% | 104.20 | 84 / 929 | 0% | 0 | 0 / 0 |
| brain | 2% | 27.02 | 66 / 2642 | 2% | 0.02 | 11 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0050830 | Biological process | defense response to Gram-positive bacterium |
| GO_0019731 | Biological process | antibacterial humoral response |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0004522 | Molecular function | ribonuclease A activity |
| GO_0004540 | Molecular function | RNA nuclease activity |
| GO_0003676 | Molecular function | nucleic acid binding |
| Gene name | RNASE4 |
| Protein name | Ribonuclease 4 (RNase 4) (EC 3.1.27.-) |
| Synonyms | RNS4 |
| Description | FUNCTION: Cleaves preferentially after uridine bases . Has antimicrobial activity against uropathogenic E.coli (UPEC) . Probably contributes to urinary tract sterility . . |
| Accessions | ENST00000397995.2 ENST00000555597.1 ENST00000555835.3 P34096 |